Estrogens in vascular biology and disease:: where do we stand today?

被引：59
|
作者：
Arnal, Jean-Francois
Scarabin, Pierre-Yves
Tremollieres, Florence
Laurell, Henrik
Gourdy, Pierre
机构：
[1] CHU Toulouse Rangueil, Dept Vasc Biol & Atherothrombosis, INSERM, U858,12MR, F-31432 Toulouse 4, France
[2] Hop Paul Brousse, Cardiovasc Epidemiol Team, Villejuif, France
来源：
CURRENT OPINION IN LIPIDOLOGY | 2007年 / 18卷 / 05期
关键词：
atheroma; atherosclerosis; cardiovascular risk; oestrogens; thrombosis;
D O I：
10.1097/MOL.0b013e3282ef3bca
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A better understanding of the balance between the deleterious and beneficial effects of estrogens is required and should help to improve hormonal therapy safety and to optimize the prevention of cardiovascular disease after menopause.
引用
收藏
页码：554 / 560
页数：7
相关论文
共 50 条
  • [31] Coronary Artery Calcium: Where Do We Stand After Over 3 Decades?
    Grundy, Scott M.
    Stone, Neil J.
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (09) : 1091 - 1095
  • [32] Primary Thrombosis Prophylaxis in Antiphospholipid Antibody–Positive Patients: Where Do We Stand?
    Medha Barbhaiya
    Doruk Erkan
    Current Rheumatology Reports, 2011, 13 : 59 - 69
  • [33] Primary Thrombosis Prophylaxis in Antiphospholipid Antibody-Positive Patients: Where Do We Stand?
    Barbhaiya, Medha
    Erkan, Doruk
    CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (01) : 59 - 69
  • [34] Pharmacokinetic and Pharmacodynamic Drug Monitoring of Direct-Acting Oral Anticoagulants: Where Do We Stand?
    Wieland, Eberhard
    Shipkova, Maria
    THERAPEUTIC DRUG MONITORING, 2019, 41 (02) : 180 - 191
  • [35] Coronary Artery Calcium Score: Where Do We Stand? Current Uses and Implications in Asymptomatic Patients
    Schamroth, Nil
    Gutstein, Ariel
    Kornowski, Ran
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2017, 19 (04): : 214 - 215
  • [36] Orthodox religious fasting as a medical nutrition therapy for dyslipidemia: where do we stand and how far can we go?
    Koufakis, Theocharis
    Karras, Spyridon N.
    Zebekakis, Pantelis
    Kotsa, Kalliopi
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2018, 72 (04) : 474 - 479
  • [37] Hypertension in Kidney Transplant Recipients: Where Are We Today?
    Ari, Elif
    Fici, Francesco
    Robles, Nicolas Roberto
    CURRENT HYPERTENSION REPORTS, 2021, 23 (04)
  • [38] Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
    Yu Zuo
    Medha Barbhaiya
    Doruk Erkan
    Current Rheumatology Reports, 2018, 20
  • [39] Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?
    Napolitano, Mariasanta
    Siragusa, Sergio
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (06) : 867 - 869
  • [40] Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?
    Zuo, Yu
    Barbhaiya, Medha
    Erkan, Doruk
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (11)
12345